SAIRA KHADERI

Concepts (153)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Hepatocellular
13
2024
935
1.710
Why?
Liver Neoplasms
13
2024
1308
1.540
Why?
Liver Cirrhosis
13
2024
823
1.270
Why?
Liver Transplantation
6
2020
1014
0.770
Why?
Alcohol Drinking
2
2024
337
0.720
Why?
Hepatitis C
4
2023
365
0.710
Why?
Early Detection of Cancer
4
2024
348
0.650
Why?
Alcoholic Beverages
1
2019
18
0.640
Why?
End Stage Liver Disease
3
2018
178
0.640
Why?
Religion
1
2019
49
0.620
Why?
Liver Diseases
2
2018
362
0.560
Why?
Hepacivirus
3
2016
241
0.560
Why?
Alcoholism
1
2019
230
0.540
Why?
Hepatitis B virus
1
2016
136
0.500
Why?
Liver Failure, Acute
1
2016
87
0.500
Why?
Digestive System Neoplasms
1
2015
14
0.490
Why?
Cholangitis, Sclerosing
1
2015
54
0.470
Why?
alpha-Fetoproteins
2
2024
131
0.440
Why?
Hypertension, Portal
1
2014
78
0.430
Why?
Antiviral Agents
2
2016
747
0.410
Why?
Liver Diseases, Alcoholic
2
2023
57
0.410
Why?
Hypertension, Pulmonary
1
2014
430
0.330
Why?
Non-alcoholic Fatty Liver Disease
2
2023
387
0.300
Why?
Esophageal and Gastric Varices
1
2008
64
0.290
Why?
Veterans
1
2018
1726
0.280
Why?
Gastrointestinal Hemorrhage
1
2008
224
0.260
Why?
Quality Improvement
2
2022
625
0.250
Why?
Prospective Studies
10
2024
6033
0.250
Why?
Risk Factors
11
2024
10015
0.230
Why?
Phospholipases A2, Calcium-Independent
1
2024
13
0.230
Why?
Humans
27
2024
123213
0.220
Why?
Bile Acids and Salts
1
2024
233
0.200
Why?
Graft Survival
2
2014
525
0.200
Why?
Middle Aged
14
2024
26009
0.190
Why?
Hepatitis, Viral, Human
1
2020
44
0.170
Why?
Program Development
1
2020
190
0.170
Why?
United States
4
2024
10633
0.160
Why?
History, 15th Century
1
2019
13
0.160
Why?
History, Medieval
1
2019
26
0.160
Why?
History, 16th Century
1
2019
27
0.160
Why?
History, Ancient
1
2019
54
0.160
Why?
Predictive Value of Tests
3
2024
2108
0.160
Why?
Pentanoic Acids
1
2018
3
0.160
Why?
Caspase Inhibitors
1
2018
29
0.150
Why?
Fatty Liver
1
2020
176
0.150
Why?
Transition to Adult Care
1
2020
119
0.150
Why?
Cystatin C
1
2018
49
0.150
Why?
Obesity
3
2024
2227
0.140
Why?
Male
16
2024
60117
0.140
Why?
Estrogen Replacement Therapy
1
2017
44
0.140
Why?
Female
17
2024
65516
0.140
Why?
Aged
10
2024
19089
0.140
Why?
Genetic Predisposition to Disease
2
2024
3084
0.140
Why?
Genome-Wide Association Study
1
2024
1641
0.130
Why?
Risk Assessment
5
2024
3328
0.130
Why?
Sofosbuvir
1
2016
13
0.130
Why?
Patient Care Team
1
2020
549
0.130
Why?
Renal Insufficiency
1
2018
233
0.120
Why?
Gallbladder Neoplasms
1
2015
13
0.120
Why?
Hepatitis B
1
2016
159
0.120
Why?
Endpoint Determination
1
2015
53
0.120
Why?
Referral and Consultation
1
2018
530
0.120
Why?
Glomerular Filtration Rate
1
2018
481
0.120
Why?
Bile Ducts, Intrahepatic
1
2015
95
0.120
Why?
United States Department of Veterans Affairs
1
2018
654
0.120
Why?
Time Factors
2
2014
6217
0.110
Why?
Treatment Outcome
5
2018
12134
0.110
Why?
Incidence
4
2024
3047
0.110
Why?
Bile Duct Neoplasms
1
2015
109
0.110
Why?
Cholangiocarcinoma
1
2015
107
0.110
Why?
Age Factors
2
2024
2802
0.110
Why?
Administration, Inhalation
1
2014
178
0.110
Why?
Administration, Intravenous
1
2014
143
0.110
Why?
Arterial Pressure
1
2014
104
0.110
Why?
Vasodilator Agents
1
2014
203
0.100
Why?
Models, Theoretical
1
2015
356
0.100
Why?
Waiting Lists
1
2014
225
0.100
Why?
Infectious Disease Transmission, Vertical
1
2014
237
0.100
Why?
Administration, Oral
1
2014
671
0.100
Why?
Hepatitis C, Chronic
1
2016
323
0.100
Why?
Drug Therapy, Combination
1
2014
1151
0.090
Why?
Pulmonary Artery
1
2014
438
0.090
Why?
Recurrence
1
2014
1422
0.090
Why?
Retrospective Studies
5
2024
16019
0.080
Why?
Colorectal Neoplasms
1
2015
560
0.080
Why?
Texas
3
2024
3558
0.080
Why?
Genotype
1
2014
2541
0.080
Why?
Portal Pressure
1
2008
5
0.080
Why?
Decision Trees
1
2008
49
0.080
Why?
Hepatic Veins
1
2008
22
0.070
Why?
Sclerotherapy
1
2008
40
0.070
Why?
Ligation
1
2008
132
0.070
Why?
Sex Factors
2
2024
1259
0.070
Why?
Decompression, Surgical
1
2008
92
0.070
Why?
Biomarkers
3
2024
2945
0.070
Why?
Esophagoscopy
1
2008
156
0.070
Why?
Angiotensin Receptor Antagonists
1
2008
121
0.070
Why?
Biomarkers, Tumor
2
2024
1430
0.070
Why?
Serum Albumin, Human
1
2024
10
0.060
Why?
Platelet Count
1
2024
133
0.060
Why?
Serum Albumin
1
2024
107
0.060
Why?
Prothrombin
1
2024
24
0.060
Why?
Acyltransferases
1
2024
45
0.060
Why?
Bilirubin
1
2024
120
0.060
Why?
Lipase
1
2024
88
0.060
Why?
Case-Control Studies
2
2024
3250
0.060
Why?
Alanine Transaminase
1
2024
151
0.060
Why?
Liver Cirrhosis, Alcoholic
1
2023
35
0.060
Why?
Protein Precursors
1
2024
149
0.060
Why?
Adolescent
3
2020
19124
0.050
Why?
North America
1
2024
236
0.050
Why?
Genetic Loci
1
2024
333
0.050
Why?
Child, Preschool
2
2015
13888
0.050
Why?
Prognosis
2
2024
4507
0.050
Why?
Proportional Hazards Models
1
2024
1305
0.050
Why?
Adult
3
2018
29091
0.040
Why?
Overweight
1
2023
358
0.040
Why?
Severity of Illness Index
1
2008
2840
0.040
Why?
Patient Care Planning
1
2020
123
0.040
Why?
Transplant Recipients
1
2020
209
0.040
Why?
Follow-Up Studies
2
2020
5047
0.040
Why?
Keratin-18
1
2018
6
0.040
Why?
Disease Progression
1
2024
2026
0.040
Why?
Quality Indicators, Health Care
1
2020
214
0.040
Why?
Serum
1
2018
46
0.040
Why?
Patient Participation
1
2020
220
0.040
Why?
Placebos
1
2018
238
0.040
Why?
Reproducibility of Results
1
2024
2842
0.040
Why?
Child
2
2015
24244
0.040
Why?
Gastroenterology
1
2020
191
0.040
Why?
Patient Education as Topic
1
2020
451
0.040
Why?
Germ-Line Mutation
1
2019
313
0.030
Why?
Membrane Proteins
1
2024
1530
0.030
Why?
Triglycerides
1
2019
562
0.030
Why?
Sustained Virologic Response
1
2016
41
0.030
Why?
Creatinine
1
2018
380
0.030
Why?
Metabolic Syndrome
1
2019
330
0.030
Why?
Polymorphism, Single Nucleotide
1
2024
2586
0.030
Why?
Double-Blind Method
1
2018
1589
0.030
Why?
Viral Load
1
2016
383
0.030
Why?
RNA, Viral
1
2016
541
0.030
Why?
Survival Analysis
1
2017
1472
0.030
Why?
Decision Support Techniques
1
2015
280
0.020
Why?
Inflammation
1
2019
1402
0.020
Why?
Multivariate Analysis
1
2015
1415
0.020
Why?
Surveys and Questionnaires
1
2020
3670
0.020
Why?
Survival Rate
1
2015
1997
0.020
Why?
Cohort Studies
1
2019
4705
0.020
Why?
Aged, 80 and over
1
2018
6373
0.020
Why?
Young Adult
1
2020
8886
0.020
Why?
Postoperative Complications
1
2015
3013
0.010
Why?
Infant, Newborn
1
2015
8107
0.010
Why?
Infant
1
2015
12347
0.010
Why?
KHADERI's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (153)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_